Pentwater Capital Management LP
Source: SEC Form 13F · as of Mar 2026Pentwater Capital Management LP holds 9 biotech & pharma companies tracked by BioSniper, totaling $2.19B in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$2.19B
BioSniper AIPage evidence connected
Prepared research question
What matters most for UnitedHealth Group Incorporated Common Stock (DE) (UNH)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,997,000 | $1.08B |
| ACLXArcellx, Inc. | 2,870,000 | $329.5M |
| CNTACentessa Pharmaceuticals plc | 8,170,000 | $324.5M |
| APLSApellis Pharmaceuticals, Inc. | 5,250,000 | $211.2M |
| FOLDAMICUS THERAPEUTICS, INC. | 14,000,000 | $202.4M |
| DAWNDay One Biopharmaceuticals, Inc. | 800,000 | $17.2M |
| GPCRStructure Therapeutics Inc. | 245,000 | $11.8M |
| RNAAtrium Therapeutics Inc. | 602,649 | $8.1M |
| PRTCPureTech Health plc | 70,000 | $1.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.